4//SEC Filing
Southwell Gavin 4
Accession 0001567619-19-002400
CIK 0001561387other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 5:35 PM ET
Size
13.9 KB
Accession
0001567619-19-002400
Insider Transaction Report
Form 4
Southwell Gavin
President and CEO
Transactions
- Sale
Class A Common Stock
2019-02-04$40.31/sh−65,899$2,656,343→ 543,824 total - Sale
Class A Common Stock
2019-04-05$40.03/sh−7,647$306,090→ 536,177 total - Sale
Class A Common Stock
2019-02-01$40.02/sh−6,150$246,113→ 609,723 total
Holdings
- 20,000
Stock Appreciation Rights
Exercise: $6.10Exp: 2023-04-26→ Class A Common Stock (20,000 underlying) - 33,333
Stock Appreciation Rights
Exercise: $5.96Exp: 2023-09-06→ Class A Common Stock (33,333 underlying) - 100,000
Stock Appreciation Rights
Exercise: $10.30Exp: 2023-11-15→ Class A Common Stock (100,000 underlying)
Footnotes (6)
- [F1]Sales made pursuant to a 10b5-1 plan previously adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.00 to $40.22, inclusive. The Reporting Person undertakes to provide Health Insurance Innovations, Inc. (the "Company), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F2]Sales made pursuant to a 10b5-1 plan previously adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.00 to $41.58, inclusive. The Reporting Person undertakes to provide Health Insurance Innovations, Inc. (the "Company), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F3]Sales made pursuant to a 10b5-1 plan previously adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.00 to $40.08, inclusive. The Reporting Person undertakes to provide Health Insurance Innovations, Inc. (the "Company), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F4]These stock-settled stock appreciation rights were granted under the Plan and vest 50% on the first anniversary of grant date and 50% on the second anniversary of grant date, subject to the terms of the Plan and an award agreement under the Plan.
- [F5]These stock-settled stock appreciation rights were granted under the Plan and vest 25% on the first anniversary of grant date, 25% on the second anniversary of grant date, and 50% on the third anniversary of grant date, subject to the terms of the Plan and an award agreement under the Plan.
- [F6]These stock-settled stock appreciation rights were granted under the Plan and vest 25% on each of the first four anniversaries of the date of grant, subject to the terms of the Plan and an award agreement under the Plan.
Documents
Issuer
Health Insurance Innovations, Inc.
CIK 0001561387
Entity typeother
Related Parties
1- filerCIK 0001678010
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 5:35 PM ET
- Size
- 13.9 KB